Supply of Tildrakizumab 100 mg/ml Injection (Ilumya) for Ministry of Defence

This tender, referenced as RC/26-27/104, is being issued by the DDG (Prov), O/o DGAFMS, Ministry of Defence, on behalf of IHQ of MoD (Army)-(OSCC) for the supply of PVMS No 016318, Inj Tildrakizumab 100 mg/ml (Ilumya). The contract type is a buy, with a bid validity period of 120 days and a work period of 45 days. The tender is categorized under Goods, specifically Drugs and Pharmaceutical Products, and requires a two-cover submission system. Essential critical dates for participation include: document download and sale commencing on 10-Sep-2026 at 06:00 PM and concluding on 06-Oct-2026 at 10:00 AM; bid submission starting on 17-Sep-2026 at 06:00 PM and closing on 06-Oct-2026 at 10:00 AM; and bid opening scheduled for 06-Oct-2026 at 11:00 AM. A significant Earnest Money Deposit (EMD) of ₹2,96,400 is required, payable to "The President of India through office of DGAFMS" in New Delhi, with EMD through Bank Guarantee/Standby Letter of Credit or EMD exemption being permitted. The tender inviting authority is located at DDG(Prov) O/o DGAFMS Ministry of Defence, 5th Floor, A Block, Defence Offices Complex, Africa Avenue, New Delhi 110023.